Immanence Intégrale Dermo Correction (IDC) signs a distribution agreement with Glenmark Pharmaceuticals Limited, a global leader in dermatology IDC
Montréal, Thursday, April 7, 2011 — Canadian company Immanence-IDC, which specializes in the development and marketing of sophisticated anti-aging cosmeceutical care, is happy to announce that it has signed a distribution agreement worth several million dollars with Glenmark Pharmaceutical Limited, one of the global leaders in dermatology, and headquartered in Mumbai, India.
To read the complete press release: